VMD
Company Description
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270.28M | 224.26M | 183.01M | 138.83M | 117.06M | 131.31M | 80.26M | 65.27M | 46.93M | 31.36M | 34.60M | 23.29M |
| Net Income | 14.93M | 11.27M | 10.24M | 6.22M | 9.13M | 31.53M | 8.53M | 10.18M | 8.18M | 1.23M | 8.93M | 9.45M |
| EPS | 0.38 | 0.29 | 0.27 | 0.15 | 0.23 | 0.86 | 0.23 | 0.27 | 0.22 | 0.03 | 1.49 | 1.58 |
| Free Cash Flow | 11.93M | 1.32M | 19.12M | 4.85M | 2.75M | 22.07M | 5.70M | 16.25M | 8.02M | 4.74M | N/A | N/A |
| FCF / Share | 0.31 | 0.03 | 0.50 | 0.13 | 0.07 | 0.57 | 0.15 | 0.43 | 0.21 | 0.13 | N/A | N/A |
| Operating CF | 51.92M | 39.09M | 45.21M | 27.75M | 22.49M | 35.11M | 19.09M | 22.37M | 12.02M | 6.41M | N/A | N/A |
| Total Assets | 214.94M | 177.07M | 154.90M | 117.04M | 117.96M | 112.56M | 82.60M | 53.52M | 37.69M | 24.68M | N/A | N/A |
| Total Debt | 15.95M | 6.87M | 10.32M | 694,000 | 6.52M | 11.13M | 19.51M | 3.42M | 5.18M | 6.49M | N/A | N/A |
| Cash & Equiv | 13.50M | 17.54M | 12.84M | 16.91M | 28.41M | 30.98M | 13.36M | 10.41M | 5.10M | 4.34M | N/A | N/A |
| Book Value | 141.54M | 131.39M | 113.89M | 97.09M | 94.82M | 81.69M | 43.70M | 35.03M | 23.74M | 12.88M | N/A | N/A |
| Return on Equity | 0.11 | 0.09 | 0.09 | 0.06 | 0.10 | 0.39 | 0.20 | 0.29 | 0.34 | 0.10 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.41M | 76.18M | 71.91M | 63.06M | 59.13M | 60.70M | 58.00M | 54.97M | 50.59M | 50.74M | 49.40M | 43.31M |
| Net Income | 2.58M | 5.64M | 3.51M | 3.16M | 2.62M | 4.32M | 3.88M | 1.47M | 1.60M | 3.48M | 2.92M | 2.33M |
| EPS | 0.07 | 0.15 | 0.09 | 0.08 | 0.07 | 0.11 | 0.10 | 0.04 | 0.04 | 0.09 | 0.07 | 0.06 |
| Free Cash Flow | 1.36M | 9.70M | 10.73M | 4.12M | (12.63M) | 3.16M | 1.74M | 1.25M | (4.83M) | 5.35M | 6.41M | 1.54M |
| FCF / Share | 0.04 | 0.26 | 0.28 | 0.10 | -0.32 | 0.08 | 0.04 | 0.03 | -0.12 | 0.14 | 0.17 | 0.04 |
| Operating CF | 8.07M | 18.44M | 18.37M | 12.25M | 2.85M | 14.99M | 12.74M | 10.18M | 1.18M | 13.28M | 13.81M | 7.62M |
| Total Assets | 197.36M | 214.94M | 202.36M | 184.60M | 178.08M | 177.07M | 169.53M | 163.95M | 154.88M | 154.90M | 149.40M | 149.12M |
| Total Debt | 12.44M | 15.95M | 24.70M | 6.89M | 6.76M | 6.87M | 7.26M | 12.47M | 9.53M | 10.32M | 10.90M | 16.34M |
| Cash & Equiv | 9.76M | 13.50M | 11.12M | 20.02M | 10.16M | 17.54M | 11.35M | 8.81M | 7.31M | 12.84M | 10.08M | 10.22M |
| Book Value | 143.86M | 141.54M | 133.61M | 139.73M | 134.76M | 131.39M | 124.96M | 119.37M | 116.27M | 113.89M | 108.81M | 104.50M |
| Return on Equity | 0.02 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 | 0.03 | 0.02 |